Cargando…
Oncolytic Adenoviruses Armed with Co-Stimulatory Molecules for Cancer Treatment
SIMPLE SUMMARY: Current cancer therapies are insufficient to cure advanced malignancies and cause off-target toxicity. Scientists have focused on developing new, more efficacious, and selective therapies to overcome these issues. This review describes a modern approach based on oncotherapy, a type o...
Autores principales: | Gryciuk, Aleksander, Rogalska, Marta, Baran, Joanna, Kuryk, Lukasz, Staniszewska, Monika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093006/ https://www.ncbi.nlm.nih.gov/pubmed/37046608 http://dx.doi.org/10.3390/cancers15071947 |
Ejemplares similares
-
The Antifungal Action Mode of N-Phenacyldibromobenzimidazoles
por: Staniszewska, Monika, et al.
Publicado: (2021) -
In Vitro Anti-Candida Activity and Action Mode of Benzoxazole Derivatives
por: Staniszewska, Monika, et al.
Publicado: (2021) -
Mast Cells as a Target—A Comprehensive Review of Recent Therapeutic Approaches
por: Baran, Joanna, et al.
Publicado: (2023) -
Combination Therapy of Novel Oncolytic Adenovirus with Anti-PD1 Resulted in Enhanced Anti-Cancer Effect in Syngeneic Immunocompetent Melanoma Mouse Model
por: Garofalo, Mariangela, et al.
Publicado: (2021) -
Prospects of Replication-Deficient Adenovirus Based Vaccine Development against SARS-CoV-2
por: Garofalo, Mariangela, et al.
Publicado: (2020)